Literature DB >> 33972165

Chemokines and the extracellular matrix: Set of targets for tumor development and treatment.

Paulo Henrique Rosa da Silva1, Bruna Cristina Borges1, Isadora Akemi Uehara1, Luiz Ricardo Soldi1, Rogério Agenor de Araújo1, Marcelo José Barbosa Silva2.   

Abstract

The extracellular matrix (ECM) consists of various molecules that support tissue cells, including proteins, fibronectin, laminin, collagen IV, and glycosaminoglycans. In addition to interactions between the ECM and cells, the ECM also interacts with chemokines, and growth factors, and these interactions ensure cell survival, development, differentiation, and migration of both immune system cells and tumor cells. This review provides an overview of the mechanisms of interaction between the ECM and chemokines, focusing on the tumor microenvironment and the modulation of these elements as a target for therapies in several types of cancer.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; Chemokines; Extracellular matrix; Progress; Recruitment; Tumor

Mesh:

Substances:

Year:  2021        PMID: 33972165     DOI: 10.1016/j.cyto.2021.155548

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.

Authors:  Martyna Maszota-Zieleniak; Ferenc Zsila; Sergey A Samsonov
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

2.  FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.

Authors:  Anyuan Zhong; Ting Chen; Yufei Xing; Xue Pan; Minhua Shi
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

3.  The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.

Authors:  Gujie Wu; Min He; Xi Yin; Wenmaio Wang; Jiabin Zhou; Kuan Ren; Xinming Chen; Qun Xue
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

4.  AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer.

Authors:  Gujie Wu; Mianxiong Chen; Hefei Ren; Xinyu Sha; Min He; Kuan Ren; Juntao Qi; Feng Lin
Journal:  Front Cell Dev Biol       Date:  2022-07-08

Review 5.  The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Authors:  Ancuta Jurj; Calin Ionescu; Ioana Berindan-Neagoe; Cornelia Braicu
Journal:  J Exp Clin Cancer Res       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.